SCHEMBL7367543

SCHEMBL7367543

CCOC(=O)c1ccc(CCC(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.58
CA12 O43570 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
ESR1 P03372 1/20 0.58
CA7 P43166 1/20 0.58
CA9 Q16790 1/20 0.58
ESR2 Q92731 1/20 0.58
CA14 Q9ULX7 1/20 0.58
LMNA P02545 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAOA P21397 1/20 0.56
NAMPT P43490 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.53
FFAR1 O14842 2/20 0.52
CYP4F2 P78329 1/20 0.51
CYP4A11 Q02928 1/20 0.51
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10586967 0.90 HSD17B10 (0.63) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL8746140 0.88 CA12 (0.59) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL12199135 0.87 CA1 (0.68) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL7482018 0.86 CA12 (0.58) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL7766764 0.86 CYP4F2 (0.70) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL571227 0.84 CA1 (0.63) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL9043770 0.83 CA12 (0.54) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL1244233 0.82 CA1 (0.61) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL10609210 0.82 CA1 (0.61) HTTSMN1; SMN2CA12CA1CA2
SCHEMBL481332 0.82 CA1 (0.61) HTTSMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102911176-B Preparation method of pemetrexed disodium DEZHOU DEYAO PHARMACEUTICAL CO LTD 2015-07-22 CN disclosed
US-5907068-A TRIFLUOROMETHYLSUBSTITUTED COMPOUND INCLUDED IN PEPTIDES ZENECA INC. (US) 1999-05-25 US disclosed
US-5726158-A INHIBITORS OF HUMAN LEUKOCYTE ELASTASE USEFUL IN TREATING TISSUE DEGENERATIVE DISEASES; TRIFLUOROMETHYL KETONE SUBSTITUTED DI-, TRI-, AND TETRA-PEPTIDE DERIVATIVES ZENECA INC. (US) 1998-03-10 US disclosed
US-5414132-A Peptide intermediates ZENECA INC. (US) 1995-05-09 US disclosed
US-5194588-A Inhibitors of human leukocyte elastase, di-, tri- and tetra-peptides ICI AMERICAS INC. (US) 1993-03-16 US disclosed
EP-0189305-B1 PEPTIDE DERIVATIVES ICI AMERICAS INC. (US) 1992-07-29 EP disclosed
US-5055450-A Di-, tri- and tetrapeptides as inhibitors of human leukocyte elastase ICI AMERICAS INC. (US) 1991-10-08 US disclosed
US-4910190-A Containing a nitrogen containing heterocycle ring structure ICI AMERICAS INC. (US) 1990-03-20 US disclosed
EP-0189305-A2 Peptide derivatives ICI AMERICAS INC. (US) 1986-07-30 EP disclosed